...
首页> 外文期刊>The journal of maternal-fetal & neonatal medicine >What is the optimal duration of oral misoprostol treatment for cervical ripening?
【24h】

What is the optimal duration of oral misoprostol treatment for cervical ripening?

机译:宫颈成熟的口服误解源治疗的最佳持续时间是多少?

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To evaluate the number of misoprostol tablets needed to obtain a Bishop score (BS)6 or a significant cervical change (2 points in BS) during cervical ripening.Methods: Retrospective study of women with term singleton pregnancies and a BS<6 taking oral misoprostol (20g first 2 doses followed by 40g every 2h) for cervical ripening.Results: We included 400 women, 72% nulliparous, mean age of 31.35.9 years and 70% with a baseline BS2. During cervical ripening, 61 (15.3%) achieved a BS6 and 205 (51.3%) a significant change in BS. The incremental risk to achieve a BS6 after 4 tablets was low (+3.25%) with an incremental probability of +12.75% for painful uterine contractions and +0.5% for abnormal fetal tracing (AFT). The incremental probability to achieve a significant change in BS after 7 tablets was low (+2.0%). 24.3% women delivered by cesarean section which likelihood significantly increased with maternal age <35 years, BMI30, nulliparity, AFT, and baseline BS2.Conclusions: The marginal benefit of giving more than 7 misoprostol tablets (14h) during cervical ripening is very low.
机译:目的:为了评估获得主教得分(BS)6所需的误狂片剂的数量或颈椎成熟期间的显着颈椎发生(BS中的2分)。方法:术语单身妊娠术语和BS <6患者的妇女的回顾性研究口服误解源(20g前2剂,每2克,每2小时为40g),用于颈椎成熟。结果:我们包括400名女性,72%的少数,平均年龄为31.35.9岁,70%,基线BS2为70%。在颈椎成熟期间,61(15.3%)达到BS6和205(51.3%)BS的显着变化。在4片剂后实现BS6的增量风险低(+ 3.25%),疼痛子宫收缩的增量概率为+ 12.75%,胎儿追踪异常+ 0.5%(AFT)。在7片剂后在BS达到显着变化的增量概率低(+ 2.0%)。 24.3%的妇女剖腹产妇女,妇女年龄的可能性显着增加<35岁,BMI30,无污垢性,AFT和基线BS2。结论:在宫颈成熟过程中给予超过7个误解片剂(14H)的边际益处非常低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号